Abbott Laboratories (ABT) Financials
Abbott Laboratories (ABT) Historical Financial Statements and Key Metrics for 1985 - 2024
Full Abbott Laboratories financials for 1985 - 2024 are available in the
US Historical Financials dataset
All financial data is sourced direct from SEC 10-Q and 10-K filings, restatements are included.
Abbott Laboratories Income Statements
(in $ 000,000's)
| Quarter End | Revenue | Gross Profit | Operating Income | Net Income | EBITDA | EPS |
| 2024-Mar-31 | 9,964 | 5,544 (55.6 %) | 1,450 (14.6 %) | 1,225 (12.3 %) | 1,450 | 0.70 |
| 2023-Dec-31 | 0 | 0 (0.0 %) | 0 (0.0 %) | 0 (0.0 %) | 0 | 0.00 |
| 2023-Sep-30 | 10,143 | 5,538 (54.6 %) | 1,647 (16.2 %) | 1,436 (14.2 %) | 2,226 | 0.82 |
| 2023-Jun-30 | 0 | 0 (0.0 %) | 0 (0.0 %) | 0 (0.0 %) | 0 | 0.00 |
| 2023-Mar-31 | 0 | 0 (0.0 %) | 0 (0.0 %) | 0 (0.0 %) | 0 | 0.00 |
| 2022-Dec-31 | 0 | 0 (0.0 %) | 0 (0.0 %) | 0 (0.0 %) | 0 | 0.00 |
| 2022-Sep-30 | 10,410 | 5,781 (55.5 %) | 1,770 (17.0 %) | 1,435 (13.8 %) | 2,714 | 0.81 |
Full historical income statements for 1985 - 2024 is included in the
US Historical Financials dataset.
Abbott Laboratories Balance Sheets
(in $ 000,000's)
| Quarter End | Total Assets | Total Liabilities | Total Debt | Total Equity | Cash & Equivalents |
| 2024-Mar-31 | 0 | 0 | 0 | 38,827 | 7,279 |
| 2023-Dec-31 | 73,214 | 34,387 | 15,873 | 38,603 | 7,279 |
| 2023-Sep-30 | 72,090 | 213 | 15,528 | 71,877 | 7,047 |
| 2023-Jun-30 | 73,354 | 35,950 | 16,846 | 37,174 | 8,155 |
| 2023-Mar-31 | 74,438 | 36,562 | 16,773 | 74,219 | 10,170 |
| 2022-Dec-31 | 74,438 | 219 | 24,295 | 36,686 | 10,170 |
| 2022-Sep-30 | 72,801 | 36,917 | 16,414 | 35,675 | 9,907 |
Full historical balance sheet data for 1985 - 2024 is included in the
US Historical Financials dataset.
Abbott Laboratories Cash Flow Statements
(in $ 000,000's)
| Quarter End | Operating Cash Flow | Investing | Financing | Free Cash Flow |
| 2024-Mar-31 | 0 | 0 | 0 | 0 |
| 2023-Dec-31 | 3,038 | -824 | -2,052 | 2,283 |
| 2023-Sep-30 | 0 | 0 | 0 | 0 |
| 2023-Jun-30 | 1,203 | -1,213 | -1,289 | 696 |
| 2023-Mar-31 | 1,143 | -462 | -1,410 | 763 |
| 2022-Dec-31 | 2,326 | -632 | -1,457 | 1,716 |
| 2022-Sep-30 | 2,780 | -484 | -1,543 | 2,313 |
Full historical cash flow data for 1985 - 2024 is included in the
US Historical Financials dataset.
Abbott Laboratories Key Valuation and Operating Metrics
| Quarter End | Market Capitalization ($ 000,000's) |
Enterprise Value ($ 000,000's) |
Price/Earnings ($ 000,000's) |
Price/Sales ($ 000,000's) |
Price/Book ($ 000,000's) |
| 2024-Mar-31 | 194,373 | 201,652 | 19.51 | 39.67 | 5.01 |
| 2023-Dec-31 | 0 | 0 | 0.00 | 0.00 | 0.00 |
| 2023-Sep-30 | 168,069 | 176,888 | 16.57 | 29.26 | 2.34 |
| 2023-Jun-30 | 0 | 0 | 0.00 | 0.00 | 0.00 |
| 2023-Mar-31 | 0 | 0 | 0.00 | 0.00 | 0.00 |
| 2022-Dec-31 | 0 | 0 | 0.00 | 0.00 | 0.00 |
| 2022-Sep-30 | 120,740 | 127,560 | 11.60 | 21.03 | 3.38 |
Full historical valuation and operating metrics for 1985 - 2024 are included in the
US Historical Financials dataset.